A katG 315 mutation alone should not lead to exclusion of isoniazid in treatment of multidrug-resistant tuberculosis Source: Eur Respir J, 50 (4) 1701696; 10.1183/13993003.01696-2017 Year: 2017
Relationship between rpoB mutations and minimum inhibitory concentrations of rifampicin in multi drug resistant strains of mycobacterium tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
RpoB and katG mutations as an epidemiologic markers of multi-drug-resistant M. tuberculosis strains isolated in Kyrgyz Republic Source: Eur Respir J 2007; 30: Suppl. 51, 455s Year: 2007
Detection of fluoroquinolones resistance mutations in mycobacterium tuberculosis by hydrolysis probes and RFLP Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Rapid molecular detection of rifampicin and isoniazid resistance and identification of mutations in resistant genes of multi-drug resistant tuberculosis (MDR-TB) patients Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
Mutations of the gyrA gene of mycobacterium tuberculosis leading to XDR tuberculosis in Kyrgyz Republic Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Molecular epidemiological characterization of rpoB mutations in rifampicin-resistant of Mycobacterium tuberculosis in Kyrgyz Republic Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Detection of mutations associated with isoniazid and rifampicin resistance in M. tuberculosis isolates from Kazakhstan Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknownSource: Eur Respir J, 58 (3) 2100783; 10.1183/13993003.00783-2021 Year: 2021
Additional region of rpoB (202-260) for rapid detection of rifampicine resistant of M. tuberculosis by PCR-SSCP Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan Source: Eur Respir J 2009; 33: 368-374 Year: 2009
Rapid genotypic assays for detection the rifampin and isoniazid resistance in M. tuberculosis strains and clinical specimens in Moldova Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
A case series of pyrazinamide mono-resistant mycobacterium tuberculosis using whole genome sequencing for diagnosis and cluster linkage. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Mutations in the of rpoB gene in multidrug resistance mycobacterium tuberculosis from North Lima, Peru Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
23S rRNA mutations in linezolid-resistant clinical isolates of M. tuberculosis: A report of two cases Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
MIC and gyrA/B genetic analyses of fluoroquinolones against mycobacterium tuberculosis isolated in Japan Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016